These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17765727)

  • 1. Endocannabinoids in the dentate gyrus.
    Frazier CJ
    Prog Brain Res; 2007; 163():319-37. PubMed ID: 17765727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minireview: Endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior.
    Gorzalka BB; Dang SS
    Endocrinology; 2012 Mar; 153(3):1016-24. PubMed ID: 22210740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid mechanisms of pain modulation.
    Hohmann AG; Suplita RL
    AAPS J; 2006 Nov; 8(4):E693-708. PubMed ID: 17233533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction.
    Lafenêtre P; Chaouloff F; Marsicano G
    Pharmacol Res; 2007 Nov; 56(5):367-81. PubMed ID: 17951068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid overactivity and intestinal inflammation.
    Di Marzo V; Izzo AA
    Gut; 2006 Oct; 55(10):1373-6. PubMed ID: 16966693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocannabinoid-mediated synaptic plasticity in the CNS.
    Chevaleyre V; Takahashi KA; Castillo PE
    Annu Rev Neurosci; 2006; 29():37-76. PubMed ID: 16776579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders.
    Bisogno T; Di Marzo V
    Pharmacol Res; 2007 Nov; 56(5):428-42. PubMed ID: 17933549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse.
    González S; Valenti M; de Miguel R; Fezza F; Fernández-Ruiz J; Di Marzo V; Ramos JA
    Br J Pharmacol; 2004 Oct; 143(4):455-64. PubMed ID: 15371286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and neuropsychiatric consequences of endocannabinoid signaling dysfunction.
    Solowij N; Monterrubio S
    Neuropsychopharmacology; 2006 Feb; 31(2):471-2. PubMed ID: 16421518
    [No Abstract]   [Full Text] [Related]  

  • 10. The endocannabinoid system: a general view and latest additions.
    De Petrocellis L; Cascio MG; Di Marzo V
    Br J Pharmacol; 2004 Mar; 141(5):765-74. PubMed ID: 14744801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action.
    Fowler CJ
    Br J Pharmacol; 2007 Nov; 152(5):594-601. PubMed ID: 17618306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the endocannabinoid system as an anticancer target.
    Malfitano AM; Ciaglia E; Gangemi G; Gazzerro P; Laezza C; Bifulco M
    Expert Opin Ther Targets; 2011 Mar; 15(3):297-308. PubMed ID: 21244344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the endocannabinoid system in drug addiction.
    Maldonado R; Valverde O; Berrendero F
    Trends Neurosci; 2006 Apr; 29(4):225-32. PubMed ID: 16483675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid system: role in glucose and energy metabolism.
    Nogueiras R; Diaz-Arteaga A; Lockie SH; Velásquez DA; Tschop J; López M; Cadwell CC; Diéguez C; Tschöp MH
    Pharmacol Res; 2009 Aug; 60(2):93-8. PubMed ID: 19559361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocannabinoid system in the brain: from biology to therapy.
    Maccarrone M
    Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):613. PubMed ID: 16375678
    [No Abstract]   [Full Text] [Related]  

  • 16. Wiring and firing neuronal networks: endocannabinoids take center stage.
    Harkany T; Mackie K; Doherty P
    Curr Opin Neurobiol; 2008 Jun; 18(3):338-45. PubMed ID: 18801434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE).
    Diana MA; Marty A
    Br J Pharmacol; 2004 May; 142(1):9-19. PubMed ID: 15100161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans.
    Van Laere K
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1719-26. PubMed ID: 17643242
    [No Abstract]   [Full Text] [Related]  

  • 19. Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex.
    Trettel J; Fortin DA; Levine ES
    J Physiol; 2004 Apr; 556(Pt 1):95-107. PubMed ID: 14742727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis may disrupt endocannabinoid brain protection mechanism.
    Shohami E; Mechoulam R
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6087-8. PubMed ID: 16606822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.